Allegra: Advanced 24-Hour Relief from Seasonal Allergy Symptoms
Allegra
| Product dosage: 120mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 120 | $0.39 | $47.00 (0%) | 🛒 Add to cart |
| 180 | $0.36 | $70.50 $65.00 (8%) | 🛒 Add to cart |
| 270 | $0.34 | $105.75 $91.00 (14%) | 🛒 Add to cart |
| 360 | $0.33
Best per pill | $141.00 $118.00 (16%) | 🛒 Add to cart |
| Product dosage: 180mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.78 | $47.00 (0%) | 🛒 Add to cart |
| 90 | $0.59 | $70.50 $53.00 (25%) | 🛒 Add to cart |
| 120 | $0.49 | $94.00 $59.00 (37%) | 🛒 Add to cart |
| 180 | $0.39 | $141.00 $70.00 (50%) | 🛒 Add to cart |
| 270 | $0.32 | $211.50 $86.00 (59%) | 🛒 Add to cart |
| 360 | $0.29
Best per pill | $282.00 $104.00 (63%) | 🛒 Add to cart |
Synonyms
| |||
Allegra (fexofenadine hydrochloride) is a leading second-generation antihistamine specifically formulated to provide non-drowsy, 24-hour relief from seasonal allergic rhinitis symptoms. As a prescription-strength medication available over-the-counter, it represents a significant advancement in allergy management, offering targeted histamine H1-receptor blockade without the sedative effects associated with earlier antihistamines. Its rapid onset of action and sustained efficacy make it a cornerstone therapy for patients seeking to maintain normal daily function during allergy seasons. Developed through rigorous clinical research, Allegra has established itself as a trusted option for both healthcare providers and patients seeking reliable symptom control.
Features
- Contains fexofenadine hydrochloride 180mg as the active pharmaceutical ingredient
- Second-generation, non-sedating antihistamine formulation
- 24-hour sustained release technology for all-day protection
- Sugar-free, lactose-free, and gluten-free composition
- Rapid onset of action with symptom relief beginning within one hour
- Available in tablet, orally disintegrating, and liquid formulations
- No known abuse potential or controlled substance classification
- Manufactured under cGMP (current Good Manufacturing Practices) standards
Benefits
- Provides complete 24-hour relief from sneezing, runny nose, and itchy, watery eyes without causing drowsiness
- Enables normal daily activities, including driving and operating machinery, without impairment
- Reduces nasal congestion and improves breathing comfort through effective histamine blockade
- Minimizes the impact of seasonal allergens on sleep quality and daytime productivity
- Offers pediatric formulations for age-appropriate allergy management in children
- Provides consistent symptom control with once-daily dosing convenience
Common use
Allegra is primarily indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 12 years and older. These symptoms include sneezing, rhinorrhea (runny nose), itchy nose/palate/throat, itchy/watery/red eyes, and nasal congestion. The medication is also approved for the treatment of chronic idiopathic urticaria (hives of unknown cause) in the same population, helping to reduce wheals (welts) and pruritus (itching). Healthcare providers may recommend Allegra for off-label uses in certain cases, such as mild allergic reactions to other substances, though such use should always be under medical supervision.
Dosage and direction
For seasonal allergic rhinitis and chronic idiopathic urticaria in adults and children 12 years and older: Take one 180mg tablet with water once daily. For children 6-11 years: The recommended dose is one 30mg tablet twice daily (approximately 12 hours apart). For children 2-5 years: The recommended dose is one 15mg tablet twice daily (approximately 12 hours apart). Administration should occur on an empty stomach, at least one hour before or two hours after food, as absorption is significantly reduced by concomitant food intake. Tablets should be swallowed whole and not crushed, chewed, or broken. The orally disintegrating formulation should be placed on the tongue immediately after opening the blister pack and allowed to dissolve before swallowing.
Precautions
Patients with renal impairment should use Allegra with caution; those with creatinine clearance less than 80 mL/min may require dosage adjustment. Elderly patients may be more susceptible to adverse effects due to decreased renal function. While Allegra is classified as non-drowsy, individual responses may vary, and patients should observe their response before engaging in activities requiring mental alertness. The medication should be used during pregnancy only if clearly needed, as adequate human studies are lacking. Nursing mothers should consult healthcare providers, as fexofenadine is excreted in human milk. Patients should avoid taking antacids containing aluminum and magnesium within 2 hours of Allegra administration, as they may decrease absorption.
Contraindications
Allegra is contraindicated in patients with known hypersensitivity to fexofenadine hydrochloride or any component of the formulation. The medication should not be used in children under 2 years of age due to limited safety and efficacy data in this population. Patients with severe renal impairment (creatinine clearance less than 30 mL/min) should avoid use unless under direct medical supervision with appropriate dosage adjustment. Concomitant use with erythromycin or ketoconazole is contraindicated due to potential interactions that may increase fexofenadine plasma concentrations.
Possible side effects
The majority of patients experience minimal side effects with Allegra. The most commonly reported adverse reactions (occurring in ≥2% of patients) include headache, drowsiness (though significantly less than with first-generation antihistamines), nausea, dyspepsia, fatigue, and dizziness. Less common side effects (<1%) may include menstrual disorders, back pain, myalgia, insomnia, nervousness, and sleep disorders. Hypersensitivity reactions, though rare, may include rash, urticaria, pruritus, and in extremely rare cases, anaphylaxis. Patients should discontinue use and seek medical attention if any severe reactions occur.
Drug interaction
Allegra has demonstrated minimal cytochrome P450 metabolism, resulting in fewer drug interactions than many other medications. However, significant interactions may occur with erythromycin and ketoconazole, which can increase fexofenadine plasma concentrations by approximately 2- to 3-fold through P-glycoprotein inhibition. Antacids containing aluminum and magnesium hydroxide can reduce fexofenadine absorption by up to 40% when taken concomitantly. Fruit juices (particularly apple, orange, and grapefruit) may decrease absorption and should be avoided within 4 hours of dosing. Caution is advised when combining with other CNS depressants, though the effect is minimal compared to sedating antihistamines.
Missed dose
If a dose is missed, take it as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed administration. For twice-daily dosing in pediatric patients, if more than 4 hours have passed since the missed dose, wait until the next scheduled dose. Maintaining consistent dosing intervals optimizes therapeutic blood levels and symptom control.
Overdose
In case of suspected overdose, immediately contact poison control or emergency medical services. Reported symptoms of overdose may include dizziness, drowsiness, and dry mouth. There is no specific antidote for fexofenadine overdose. Treatment should be supportive and symptomatic, including gastric lavage if presented within one hour of ingestion. Activated charcoal may be administered to reduce absorption. Hemodialysis is unlikely to be effective due to fexofenadine’s high protein binding and extensive tissue distribution. Monitor vital signs and provide appropriate supportive care based on clinical presentation.
Storage
Store Allegra at room temperature (20-25°C or 68-77°F) in its original packaging. Protect from excessive moisture and light. Keep the blister packs intact until immediately before use. Do not store in bathrooms or other humid areas. Keep out of reach of children and pets. Do not use beyond the expiration date printed on the packaging. Proper storage ensures medication stability and effectiveness throughout the shelf life.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Individual responses to medication may vary. Always consult with a qualified healthcare professional before starting, stopping, or changing any medication regimen. Follow the dosage instructions provided by your healthcare provider or the product labeling. Do not use Allegra for conditions other than those for which it was prescribed or recommended. Report any adverse effects to your healthcare provider promptly.
Reviews
Clinical studies demonstrate that Allegra provides effective relief for seasonal allergy symptoms with minimal side effects. In randomized controlled trials, 180mg fexofenadine demonstrated significant improvement in total symptom scores compared to placebo (p<0.001), with particular efficacy in reducing nasal congestion. Patient satisfaction surveys indicate high rates of continued use due to the non-sedating properties and 24-hour duration of action. Healthcare providers frequently recommend Allegra as a first-line therapy for seasonal allergic rhinitis, noting its favorable safety profile and minimal drug interaction potential compared to other antihistamines.